Telacebec (Q203), a New Antituberculosis Agent
نویسندگان
چکیده
منابع مشابه
Southeast Asian Medicinal Plants as a Potential Source of Antituberculosis Agent
Despite all of the control strategies, tuberculosis (TB) is still a major cause of death globally and one-third of the world's population is infected with TB. The drugs used for TB treatment have drawbacks of causing adverse side effects and emergence of resistance strains. Plant-derived medicines have since been used in traditional medical system for the treatment of numerous ailments worldwid...
متن کاملA QUANTUM CHEMICAL STUDY OF THE CONFORMATION OF ALINIDINE A NEW ANTIARRHYTHMIC AGENT
The conformation of alinidine a new and specific bradycardic agent was studied using MNDO method. It has been found that the rotation of both phenyl and imidazoline ring of this compound is restricted. Of two possible isomers of irnidazoline ring, the one with NH in the cis position to allyl side chain is slightly more stable. On the other hand, the allyl group can rotate freely and at leas...
متن کاملEvaluation of new antituberculosis drugs in mouse models.
In the study of the activity of PA-824 in mice performed by Nuermberger et al. (3), the authors observe that “regimens were not statistically different on the primary outcome” and propose that new studies using shorter regimens are needed “to determine conclusively whether substitution of PA-824 for isoniazid has the potential” to shorten treatment in humans. We agree but have concerns about th...
متن کاملNew Antituberculosis Drugs: From Clinical Trial to Programmatic Use
Treatment of multidrug-resistant tuberculosis (MDR-TB) cases is challenging because it relies on second-line drugs that are less potent and more toxic than those used in the clinical management of drug-susceptible TB. Moreover, treatment outcomes for MDR-TB are generally poor compared to drug sensitive disease, highlighting the need for of new drugs. For the first time in more than 50 years, tw...
متن کاملEcolid: a new hypotensive agent.
During the past five years ganglion-blocking agents have been used extensively in the treatment of arterial hypertension. The discovery of the activity of hexamethonium by Paton and Zaimis (1949) placed at our disposal an active therapeutic agent capable of producing a substantial reduction in the blood pressure. Subsequent research has been directed to the synthesis of new drugs offering advan...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: New England Journal of Medicine
سال: 2020
ISSN: 0028-4793,1533-4406
DOI: 10.1056/nejmc1913327